In-Silico Molecular Docking Studies of Cymbopogon Nardus Compounds against Malarial Targets of Plasmodium falciparum

Fuente: Zenodo
Salvato in:
Dettagli Bibliografici
Autori principali: Raghuma, Reddy, B, Krishnaveni, Mamidala, Estari
Natura: Recurso digital
Lingua:inglese
Pubblicazione: Zenodo 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866901925878824960
author Raghuma, Reddy
B, Krishnaveni
Mamidala, Estari
author_facet Raghuma, Reddy
B, Krishnaveni
Mamidala, Estari
contents <p><strong><span lang="EN-IN">ABSTRACT</span></strong></p> <p><span lang="EN-IN"> </span><span>Malaria<span> </span>caused<span> </span>by<span> </span>genus<span> </span>Plasmodium,<span> </span>is<span> </span>a<span> </span>parasite<span> </span>which<span> </span>is<span> </span>the<span> </span>main<span> </span>health<span> </span>issue<span> </span>for<span> </span>humans<span> </span>and about<span> </span>half<span> </span>of<span> </span>the<span> </span>population<span> </span>were<span> </span>suffered.<span> </span>Every<span> </span>year,<span> </span>approximately<span> </span>1.2–2.7<span> </span>million<span> </span>people<span> </span>died due<span> </span>to<span> </span>malaria<span> </span>globally. Therefore,<span> </span>to prevent<span> </span>the<span> </span>spreading<span> </span>of<span> </span>malaria<span> </span>from<span> </span>the<span> </span>glob<span> </span>novel<span> </span>active drugs with specific activities are necessary. The present study aimed to identify novel drug molecule<span> </span>together<span> </span>with<span> </span>the<span> </span>bioinformatic<span> </span>tools<span> </span>for<span> </span>the<span> </span>development<span> </span>of<span> </span>active<span> </span>malarial<span> </span>drugs.<span> </span>After brief study of physiological activity of <em>Plasmodium falciparum </em>few enzymes such as PfGST, PfLDH and PfPKG are involved in the metabolism of the <em>P</em>. <em>falciparum </em>are observed as a target. Thirteen<span> </span>compounds<span> </span>which<span> </span>are<span> </span>components<span> </span>of<span> </span><em>Cymbopogon<span> </span>nardus<span> </span></em>used<span> </span>as<span> </span>ligands<span> </span>were<span> </span>got<span> </span>from the Pub Chem database and docked against the selected enzymes with Autodock software. Some of the compounds Germacrene-D-4-ol, Beta-cubebene, and Elemol showed drug-like characteristics<span> </span>and<span> </span>presents<span> </span>a<span> </span>significant<span> </span>antimalarial<span> </span>action<span> </span>in<span> </span><em>in-silico<span> </span></em>level.<span> </span>Results<span> </span>have<span> </span>outlined the significance of Compounds Germacrene-D-4-ol, Beta-cubebene, and Elemol as a promising antimalarial agent, which can be further evaluated and used for antimalarial drug development</span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18779083
institution Zenodo
language eng
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle In-Silico Molecular Docking Studies of Cymbopogon Nardus Compounds against Malarial Targets of Plasmodium falciparum
Raghuma, Reddy
B, Krishnaveni
Mamidala, Estari
PfGST, PfLDH, PfPKG, Plasmodium falciparum, Cymbopogon nardus, Autodock
<p><strong><span lang="EN-IN">ABSTRACT</span></strong></p> <p><span lang="EN-IN"> </span><span>Malaria<span> </span>caused<span> </span>by<span> </span>genus<span> </span>Plasmodium,<span> </span>is<span> </span>a<span> </span>parasite<span> </span>which<span> </span>is<span> </span>the<span> </span>main<span> </span>health<span> </span>issue<span> </span>for<span> </span>humans<span> </span>and about<span> </span>half<span> </span>of<span> </span>the<span> </span>population<span> </span>were<span> </span>suffered.<span> </span>Every<span> </span>year,<span> </span>approximately<span> </span>1.2–2.7<span> </span>million<span> </span>people<span> </span>died due<span> </span>to<span> </span>malaria<span> </span>globally. Therefore,<span> </span>to prevent<span> </span>the<span> </span>spreading<span> </span>of<span> </span>malaria<span> </span>from<span> </span>the<span> </span>glob<span> </span>novel<span> </span>active drugs with specific activities are necessary. The present study aimed to identify novel drug molecule<span> </span>together<span> </span>with<span> </span>the<span> </span>bioinformatic<span> </span>tools<span> </span>for<span> </span>the<span> </span>development<span> </span>of<span> </span>active<span> </span>malarial<span> </span>drugs.<span> </span>After brief study of physiological activity of <em>Plasmodium falciparum </em>few enzymes such as PfGST, PfLDH and PfPKG are involved in the metabolism of the <em>P</em>. <em>falciparum </em>are observed as a target. Thirteen<span> </span>compounds<span> </span>which<span> </span>are<span> </span>components<span> </span>of<span> </span><em>Cymbopogon<span> </span>nardus<span> </span></em>used<span> </span>as<span> </span>ligands<span> </span>were<span> </span>got<span> </span>from the Pub Chem database and docked against the selected enzymes with Autodock software. Some of the compounds Germacrene-D-4-ol, Beta-cubebene, and Elemol showed drug-like characteristics<span> </span>and<span> </span>presents<span> </span>a<span> </span>significant<span> </span>antimalarial<span> </span>action<span> </span>in<span> </span><em>in-silico<span> </span></em>level.<span> </span>Results<span> </span>have<span> </span>outlined the significance of Compounds Germacrene-D-4-ol, Beta-cubebene, and Elemol as a promising antimalarial agent, which can be further evaluated and used for antimalarial drug development</span></p>
title In-Silico Molecular Docking Studies of Cymbopogon Nardus Compounds against Malarial Targets of Plasmodium falciparum
topic PfGST, PfLDH, PfPKG, Plasmodium falciparum, Cymbopogon nardus, Autodock
url https://doi.org/10.5281/zenodo.18779083